Philip Brenner

885 total citations
27 papers, 664 citations indexed

About

Philip Brenner is a scholar working on Pharmacology, Psychiatry and Mental health and Pathology and Forensic Medicine. According to data from OpenAlex, Philip Brenner has authored 27 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 11 papers in Psychiatry and Mental health and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Philip Brenner's work include Treatment of Major Depression (11 papers), Multiple Sclerosis Research Studies (10 papers) and Tryptophan and brain disorders (7 papers). Philip Brenner is often cited by papers focused on Treatment of Major Depression (11 papers), Multiple Sclerosis Research Studies (10 papers) and Tryptophan and brain disorders (7 papers). Philip Brenner collaborates with scholars based in Sweden, United States and Finland. Philip Brenner's co-authors include Fredrik Piehl, Johan Reutfors, Lena Brandt, Allitia DiBernardo, Robert Bodén, Jan Hillert, Jussi Jokinen, Therése Andersson, Gang Li and Kyla A. McKay and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Philip Brenner

25 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Brenner Sweden 14 222 215 195 179 85 27 664
Helge Hasselmann Germany 9 113 0.5× 68 0.3× 80 0.4× 113 0.6× 87 1.0× 9 509
Maryia Zhdanava United States 11 24 0.1× 229 1.1× 187 1.0× 122 0.7× 86 1.0× 70 660
Yvonne Paelecke–Habermann Germany 9 61 0.3× 148 0.7× 245 1.3× 33 0.2× 81 1.0× 14 625
Pei‐Shen Ho Taiwan 15 24 0.1× 120 0.6× 172 0.9× 165 0.9× 66 0.8× 38 584
Ida S. Haussleiter Germany 14 61 0.3× 68 0.3× 130 0.7× 47 0.3× 142 1.7× 38 510
Aylin Yazıcı Türkiye 11 84 0.4× 142 0.7× 82 0.4× 50 0.3× 147 1.7× 26 502
Pablo Romero‐Sanchiz Spain 15 44 0.2× 101 0.5× 44 0.2× 103 0.6× 137 1.6× 37 543
Murat Semız Türkiye 12 63 0.3× 29 0.1× 285 1.5× 164 0.9× 126 1.5× 34 594
Yi‐Wei Yeh Taiwan 14 23 0.1× 74 0.3× 119 0.6× 126 0.7× 70 0.8× 52 542
H. Walter Austria 10 117 0.5× 78 0.4× 148 0.8× 16 0.1× 124 1.5× 31 733

Countries citing papers authored by Philip Brenner

Since Specialization
Citations

This map shows the geographic impact of Philip Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Brenner more than expected).

Fields of papers citing papers by Philip Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Brenner. The network helps show where Philip Brenner may publish in the future.

Co-authorship network of co-authors of Philip Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Brenner. A scholar is included among the top collaborators of Philip Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Brenner. Philip Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsson, Pär, et al.. (2026). Factors associated with long-term hypnotics use in depression. Journal of Affective Disorders. 403. 121415–121415.
2.
Reutfors, Johan, et al.. (2025). Risk of major adverse cardiovascular events in treatment-resistant or severe depression. Journal of Affective Disorders. 386. 119419–119419.
3.
Wintzell, Viktor, Philip Brenner, Linda Halldner, et al.. (2025). Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children. JAMA Pediatrics. 179(4). 418–418. 3 indexed citations
4.
Brenner, Philip, Johan Askling, David Hägg, et al.. (2024). Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden. General Hospital Psychiatry. 89. 23–31. 1 indexed citations
5.
Brenner, Philip, et al.. (2024). Trends in hypnotic drug use in depression 2007–2017: A Swedish population‐based study. Journal of Sleep Research. 34(1). e14267–e14267. 3 indexed citations
6.
7.
Taipale, Heidi, Johan Reutfors, Antti Tanskanen, et al.. (2020). Risk and risk factors for disability pension among patients with treatment resistant depression– a matched cohort study. BMC Psychiatry. 20(1). 232–232. 17 indexed citations
8.
Hägg, David, Philip Brenner, Johan Reutfors, et al.. (2020). A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions. PLoS ONE. 15(7). e0236434–e0236434. 19 indexed citations
9.
Li, Gang, Daniel Fife, Grace Wang, et al.. (2019). All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population. Annals of General Psychiatry. 18(1). 23–23. 58 indexed citations
10.
Brenner, Philip, Lena Brandt, Gang Li, et al.. (2019). Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study. Addiction. 114(7). 1274–1282. 27 indexed citations
11.
12.
Reutfors, Johan, Therése Andersson, Antti Tanskanen, et al.. (2019). Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study. Archives of Suicide Research. 25(3). 424–438. 40 indexed citations
13.
DiBernardo, Allitia, Xiwu Lin, Qiaoyi Zhang, et al.. (2018). Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study. BMC Psychiatry. 18(1). 352–352. 48 indexed citations
14.
Brenner, Philip, et al.. (2018). Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers. Psychoneuroendocrinology. 89. 53–58. 28 indexed citations
15.
Reutfors, Johan, Therése Andersson, Philip Brenner, et al.. (2018). Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden. Journal of Affective Disorders. 238. 674–679. 78 indexed citations
16.
Brenner, Philip, Ellenor Mittendorfer‐Rutz, Jussi Jokinen, et al.. (2016). Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls. Social Psychiatry and Psychiatric Epidemiology. 51(7). 1047–1054. 2 indexed citations
17.
Brenner, Philip & Fredrik Piehl. (2016). Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions. Acta Neurologica Scandinavica. 134. 47–54. 81 indexed citations
18.
Björkenstam, Charlotte, Petter Tinghög, Philip Brenner, et al.. (2015). Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?. BMC Psychiatry. 15(1). 286–286. 5 indexed citations
19.
Aeinehband, Shahin, Philip Brenner, Sara Ståhl, et al.. (2015). Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms. Brain Behavior and Immunity. 51. 47–55. 62 indexed citations
20.
Brenner, Philip, Kristina Alexanderson, Charlotte Björkenstam, et al.. (2014). Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study. PLoS ONE. 9(8). e104165–e104165. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helge Hasselmann Breakdown of academic impact, for papers by Maryia Zhdanava Breakdown of academic impact, for papers by Yvonne Paelecke–Habermann Breakdown of academic impact, for papers by Pei‐Shen Ho Breakdown of academic impact, for papers by Ida S. Haussleiter Breakdown of academic impact, for papers by Aylin Yazıcı Breakdown of academic impact, for papers by Pablo Romero‐Sanchiz Breakdown of academic impact, for papers by Murat Semız Breakdown of academic impact, for papers by Yi‐Wei Yeh Breakdown of academic impact, for papers by H. Walter
Rankless by CCL
2026